In the realm of investment opportunities, biotechnology stands out as a rapidly evolving field with immense potential. Over the past two decades, groundbreaking advances in biotechnology have not only transformed healthcare, but have also presented unique investment opportunities. Innovation shifts and scientific breakthroughs have opened doors to promising investment avenues that are often overlooked and unexplored by mainstream investors.
It's no secret that advances in biotechnology have materially improved human life in new ways. After first being achieved in 2002, the cost of sequencing an individual genome has declined from over $1 million in 2008 to under $1,000 today and revolutionary medicines have followed. Children with previously incurable diseases like spinal muscular atrophy can now lead more normal lives, survival rates for many cancers have improved dramatically, and developments in areas such as immunotherapy now offer hope where there previously was none. Despite these remarkable advances, it's often overlooked how little exposure most investors have to these game-changing therapies and the economic windfalls they can bring.